1. Hesperidin Inhibits UVB-Induced VEGF Production and Angiogenesis via the Inhibition of PI3K/Akt Pathway in HR-1 Hairless Mice
   Ki Mo Kim et al, 2021, Biological and Pharmaceutical Bulletin CrossRef
2. Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)
   E. Bompas et al, 2015, Annals of Oncology CrossRef
3. Emerging target discovery and drug repurposing opportunities in chordoma
   Daniel M. Freed et al, 2022, Frontiers in Oncology CrossRef
4. Efficacy of pazopanib and sunitinib in advanced axial chordoma: a single reference centre case series
   Astrid Lipplaa et al, 2016, Clinical Sarcoma Research CrossRef
5. Durable stabilization of three chordoma cases by bevacizumab and erlotinib
   T. Asklund et al, 2014, Acta Oncologica CrossRef
6. Investigating Microenvironmental Regulation of Human Chordoma Cell Behaviour
   Priya Patel et al, 2014, PLoS ONE CrossRef
7. Protein phosphatase 2A inhibition enhances radiation sensitivity and reduces tumor growth in chordoma
   Shuyu Hao et al, 2018, Neuro-Oncology CrossRef
8. Apatinib in patients with advanced chordoma: a single-arm, single-centre, phase 2 study
   Chao Liu et al, 2020, The Lancet Oncology CrossRef
9. Systemic Therapy, Trials, and Future Directions for Chordoma of the Spine
   Daniel J. Zabransky et al, 2021, Chordoma of the Spine CrossRef
10. Molecular Drivers in Chordoma
    Ahmed Mohyeldin et al, 2018, Chordomas and Chondrosarcomas of the Skull Base and Spine CrossRef
11. Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identity
    Hadley E. Sheppard et al, 2021, Cell Reports Medicine CrossRef
12. Molecular targeted therapies in advanced or metastatic chordoma patients: Facts and hypotheses
    Loïc Lebellec et al, 2015, Critical Reviews in Oncology/Hematology CrossRef
13. Clinicopathologic implications of CD8+/Foxp3+ ratio and miR-574-3p/PD-L1 axis in spinal chordoma patients
    Ming-Xiang Zou et al, 2018, Cancer Immunology, Immunotherapy CrossRef
14. Dysregulated Epigenetics of Chordoma: Prognostic Markers and Therapeutic Targets
    Hem Shukla et al, 2022, Current Cancer Drug Targets CrossRef
15. Quantitative assessment and clinical relevance of VEGFRs-positive tumor cells in refractory brain tumors
    Ryota Tamura et al, 2020, Experimental and Molecular Pathology CrossRef
16. Methylation-based reclassification and risk stratification of skull-base chordomas
    Xulei Huo et al, 2022, Frontiers in Oncology CrossRef
17. Prognostic and Therapeutic Markers in Chordomas: A Study of 287 Tumors
    Arnault Tauziède-Espariat et al, 2016, Journal of Neuropathology & Experimental Neurology CrossRef
18. Notochordal Tumors
    Takehiko Yamaguchi et al, 2017, Surgical Pathology Clinics CrossRef
19. Chordoma: To know means to recognize
    Emija Nikola Karele et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
20. Microenvironmental Targets in Sarcoma
    Monika Ehnman et al, 2015, Frontiers in Oncology CrossRef
21. Advancement of PI3 Kinase Inhibitor Combination Therapies for PI3K-Aberrant Chordoma
    Molly E. Heft Neal et al, 2022, Journal of Neurological Surgery Part B: Skull Base CrossRef
22. Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group (GSF/GETO)
    Loic Lebellec et al, 2016, Oncotarget CrossRef
23. Prognostic factors in spinal chordoma: A systematic review
    Ming-Xiang Zou et al, 2015, Clinical Neurology and Neurosurgery CrossRef
24. Prognostic Biomarkers in Spinal Chordoma: A Systematic Review
    Ming-Xiang Zou et al, 2016, Journal of Neuropathology & Experimental Neurology CrossRef
25. Biological Screening of Polyphenol Derivatives for Anti‐Proliferative, Anti‐Apoptotic and Anti‐Migrative Activities in Human Breast Cancer Cell Lines MCF‐7
    Seçil Erden Tayhan et al, 2023, Chemistry & Biodiversity CrossRef
26. The Relationship Between Tumor-Stroma Ratio, the Immune Microenvironment, and Survival in Patients With Spinal Chordoma
    Ming-Xiang Zou et al, 2019, Neurosurgery CrossRef
27. Prognostic significance of VEGF receptors expression on the tumor cells in skull base chordoma
    Yukina Morimoto et al, 2019, Journal of Neuro-Oncology CrossRef